Gα12 regulates osteoclastogenesis by modulating NFATc1 expression.
Min-Kyoung SongCheolkyu ParkYong Deok LeeHaemin KimMin Kyung KimJun-Oh KwonJa Hyun KooMin Sung JooSang Geon KimHong-Hee KimPublished in: Journal of cellular and molecular medicine (2017)
The G12 family of G protein alpha subunits has been shown to participate in the regulation of various physiological processes. However, the role of Gα12 in bone physiology has not been well described. Here, by micro-CT analysis, we discovered that Gα12-knockout mice have an osteopetrotic phenotype. Histological examination showed lower osteoclast number in femoral tissue of Gα12-knockout mice compared to wild-type mice. Additionally, in vitro osteoclastic differentiation of precursor cells with receptor activator of nuclear factor-κB ligand (RANKL) showed that Gα12 deficiency decreased the number of osteoclast generated and the bone resorption activity. The induction of nuclear factor of activated T-cell c1 (NFATc1), the key transcription factor of osteoclastogenesis, and the activation of RhoA by RANKL was also significantly suppressed by Gα12 deficiency. We further found that the RANKL induction of NFATc1 was not dependent on RhoA signalling, while osteoclast precursor migration and bone resorption required RhoA in the Gα12-mediated regulation of osteoclasts. Therefore, Gα12 plays a role in differentiation through NFATc1 and in cell migration and resorption activity through RhoA during osteoclastogenesis.
Keyphrases
- bone loss
- nuclear factor
- toll like receptor
- wild type
- cell migration
- transcription factor
- induced apoptosis
- poor prognosis
- computed tomography
- inflammatory response
- magnetic resonance imaging
- type diabetes
- cell cycle arrest
- contrast enhanced
- oxidative stress
- binding protein
- dna binding
- postmenopausal women
- soft tissue